312 related articles for article (PubMed ID: 25595827)
1. Management of the axilla: has Z0011 had an impact?
Joyce DP; Lowery AJ; McGrath-Soo LB; Downey E; Kelly L; O'Donoghue GT; Barry M; Hill AD
Ir J Med Sci; 2016 Feb; 185(1):145-9. PubMed ID: 25595827
[TBL] [Abstract][Full Text] [Related]
2. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
Mann JM; Wu X; Christos P; Nagar H
Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
[TBL] [Abstract][Full Text] [Related]
3. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
Tsao MW; Cornacchi SD; Hodgson N; Simunovic M; Thabane L; Cheng J; O'Brien MA; Strang B; Mukherjee SD; Lovrics PJ
Ann Surg Oncol; 2016 Oct; 23(10):3354-64. PubMed ID: 27342830
[TBL] [Abstract][Full Text] [Related]
4. Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.
Caretta-Weyer H; Greenberg CG; Wilke LG; Weiss J; LoConte NK; Decker M; Steffens NM; Smith MA; Neuman HB
Ann Surg Oncol; 2013 Dec; 20(13):4145-52. PubMed ID: 23959051
[TBL] [Abstract][Full Text] [Related]
5. Healthcare Costs Reduced After Incorporating the Results of the American College of Surgeons Oncology Group Z0011 Trial into Clinical Practice.
Fillion MM; Glass KE; Hayek J; Wehr A; Phillips G; Terando A; Agnese DM
Breast J; 2017 May; 23(3):275-281. PubMed ID: 27900818
[TBL] [Abstract][Full Text] [Related]
6. The impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial: An institutional review.
Le VH; Brant KN; Blackhurst DW; Schammel CM; Schammel DP; Cornett WR; McKinley BP
Breast; 2016 Oct; 29():117-9. PubMed ID: 27479042
[TBL] [Abstract][Full Text] [Related]
7. Sentinel Lymph Node Frozen-Section Utilization Declines After Publication of American College of Surgeons Oncology Group Z0011 Trial Results With No Change in Subsequent Surgery for Axillary Lymph Node Dissection.
Jorns JM; Kidwell KM
Am J Clin Pathol; 2016 Jul; 146(1):57-66. PubMed ID: 27373347
[TBL] [Abstract][Full Text] [Related]
8. Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.
Boland MR; Prichard RS; Daskalova I; Lowery AJ; Evoy D; Geraghty J; Rothwell J; Quinn CM; O'Doherty A; McDermott EW
Eur J Surg Oncol; 2015 Apr; 41(4):559-65. PubMed ID: 25648466
[TBL] [Abstract][Full Text] [Related]
9. Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.
Gatzemeier W; Mann GB
Breast; 2013 Jun; 22(3):211-6. PubMed ID: 23478200
[TBL] [Abstract][Full Text] [Related]
10. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.
Weiss A; Mittendorf EA; DeSnyder SM; Hwang RF; Bea V; Bedrosian I; Hoffman K; Adrade B; Sahin AA; Kuerer HM; Hunt KK; Caudle AS
Clin Breast Cancer; 2018 Aug; 18(4):276-281. PubMed ID: 29100726
[TBL] [Abstract][Full Text] [Related]
11. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.
Poodt IGM; Spronk PER; Vugts G; van Dalen T; Peeters MTFDV; Rots ML; Kuijer A; Nieuwenhuijzen GAP; Schipper RJ
Ann Surg; 2018 Dec; 268(6):1084-1090. PubMed ID: 28742702
[TBL] [Abstract][Full Text] [Related]
12. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.
Delpech Y; Bricou A; Lousquy R; Hudry D; Jankowski C; Willecocq C; Thoury A; Loustalot C; Coutant C; Barranger E
Ann Surg Oncol; 2013 Aug; 20(8):2556-61. PubMed ID: 23456432
[TBL] [Abstract][Full Text] [Related]
13. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
Robinson KA; Pockaj BA; Wasif N; Kaufman K; Gray RJ
Am J Surg; 2014 Dec; 208(6):1060-4; discussion 1063-4. PubMed ID: 25312842
[TBL] [Abstract][Full Text] [Related]
14. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
15. Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.
Ong CT; Thomas SM; Blitzblau RC; Fayanju OM; Park TS; Plichta JK; Rosenberger LH; Hyslop T; Shelley Hwang E; Greenup RA
Ann Surg Oncol; 2017 Nov; 24(12):3559-3566. PubMed ID: 28879416
[TBL] [Abstract][Full Text] [Related]
16. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
[TBL] [Abstract][Full Text] [Related]
17. [Impact of omission of axillary dissection on adjuvant therapy in patients with metastatic sentinel lymph nodes according to the ACOSOG Z0011 criteria].
Roosen A; Lousquy R; Bricou A; Delpech Y; Selz J; Le Maignan C; Bousquet G; Winterman S; Zelek L; Barranger E
Gynecol Obstet Fertil; 2014 Jun; 42(6):409-14. PubMed ID: 24861437
[TBL] [Abstract][Full Text] [Related]
18. Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial.
Shah-Khan M; Boughey JC
Cancer Control; 2012 Oct; 19(4):267-76. PubMed ID: 23037494
[TBL] [Abstract][Full Text] [Related]
19. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
[TBL] [Abstract][Full Text] [Related]
20. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
